Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 68.32 USD -0.73% Market Closed
Market Cap: $3.2B

Operating Margin

19.1%
Current
Improving
by 3.2%
vs 3-y average of 16%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19.1%
=
Operating Income
$253.8m
/
Revenue
$1.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
19.1%
=
Operating Income
$253.8m
/
Revenue
$1.3B

Peer Comparison

Country Company Market Cap Operating
Margin
US
Haemonetics Corp
NYSE:HAE
3.2B USD
Loading...
JP
Hoya Corp
TSE:7741
8.5T JPY
Loading...
CH
Alcon AG
SIX:ALC
31B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.2B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.3B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
43.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
Loading...
KR
HLB Inc
KOSDAQ:028300
7.5T KRW
Loading...

Market Distribution

Higher than 78% of companies in the United States of America
Percentile
78th
Based on 14 112 companies
78th percentile
19.1%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Haemonetics Corp
Glance View

In the realm of healthcare, Haemonetics Corp. operates as a pivotal player, bridging the gap between innovation and life-saving technology. Founded in 1971, the company has evolved to become a leader in blood management solutions, riding the wave of advanced medical technology to cater primarily to hospitals and blood collection centers. At its core, Haemonetics specializes in products and software designed to optimize the collection, processing, and surgical use of blood. Among its notable contributions are devices for blood component separation and coagulation management systems, which play a critical role in ensuring that patients around the world receive safe and effective blood therapy. Revenue streams for Haemonetics come from a diverse range of blood management systems and services. Their offerings are not limited to physical products; the company also provides comprehensive software solutions that help institutions maximize efficiencies and improve patient outcomes. With a keen focus on research and development, Haemonetics continuously innovates to meet the stringent demands of the modern healthcare landscape. Their business model thrives on a combination of direct sales, strategic partnerships, and service agreements with hospitals and blood banks, all while maintaining a strong commitment to quality and regulatory compliance. Through its strategic approach, Haemonetics not only fulfills an essential healthcare need but also crafts a sustainable financial pathway by redefining how blood and related products are managed globally.

HAE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
19.1%
=
Operating Income
$253.8m
/
Revenue
$1.3B
What is Haemonetics Corp's current Operating Margin?

The current Operating Margin for Haemonetics Corp is 19.1%, which is above its 3-year median of 16%.

How has Operating Margin changed over time?

Over the last 3 years, Haemonetics Corp’s Operating Margin has increased from 13% to 19.1%. During this period, it reached a low of 12.9% on Dec 31, 2022 and a high of 19.1% on Sep 27, 2025.

Back to Top